ELMED
Back to BlogAnnouncements

ELMED Inaugurates State-of-the-Art R&D Fermentation Facility

Our new 2,400 sq. ft. R&D fermentation lab is now operational, doubling our strain development capacity and enabling faster time-to-prototype for contract manufacturing clients.

ELMED Research TeamJanuary 10, 20262 min read

ELMED Life Sciences has officially inaugurated a new Research & Development fermentation facility at our Hyderabad campus. The 2,400 sq. ft. lab is equipped with a 12-vessel pilot fermentation suite, advanced anaerobic chambers, and high-throughput automated colony-counting systems.

What This Means for Contract Manufacturing Partners

The facility is designed to support clients from initial feasibility studies through to commercial scale-up, providing a seamless innovation pipeline.

  • Custom strain development turnaround reduced from 16 weeks to 8 weeks
  • Pilot-scale fermentation for new formulations before full production commitment
  • Enhanced anaerobic culture capability for oxygen-sensitive organisms
  • Dedicated stability chambers for accelerated shelf-life studies

Innovations in Development

The new facility will accelerate several ongoing programmes including next-generation psychobiotic formulations (gut-brain axis), heat-stable probiotic formats for high-temperature food applications, and multi-strain synbiotic combinations with prebiotic fibres.

Stay in the Loop

Get the latest probiotic industry insights delivered to your inbox.